FILTER CONTENT

Filtered (58)
Filters
Post Date
Company Names
Show (58)
Cancel

Research

  • 7investing logo next to the Veeva Systems logo.
    By Published On: February 17, 2025

    Veeva’s Slow-and-Steady Results Are Winning the Software Race; Shares Still a “Buy”

    Veeva's third quarter 2025 results demonstrated that its growth is continuing to slow, [...]

  • By Published On: September 19, 2024

    September 2024 Conviction Rating Review

  • By Published On: August 26, 2024

    Here are 3 Key Risks at TransMedics. But the Stock is Still a Buy.

  • By Published On: August 19, 2024

    7investing Exclusive: Sell These 8 Stocks

  • By Published On: August 19, 2024

    Sell Seres Therapeutics

  • By Published On: August 19, 2024

    August 2024 Conviction Rating Review

  • By Published On: June 11, 2024

    Seres is Blowing Up its Business. Here’s What Investors Need to Know.

  • By Published On: December 18, 2023

    7investing’s 2023 Year in Review: An Updated Look at All of Our Stock Picks

  • By Published On: October 19, 2023

    The Seres Dilemma: VOWST is Approved, But the Stock is Falling

  • 7investing logo next to the Splunk logo.
    By Published On: September 27, 2023

    Sell Splunk

  • 7investing logo next to the Rocket Lab logo.
    By Published On: September 15, 2023

    Rocket Lab Moves Upmarket; Upgrading to “Best Buy”

  • By Published On: July 13, 2023

    Rocket Lab is Hitting an Important Inflection Point

  • 7investing logo next to the Rocket Lab logo.
    By Published On: July 10, 2023

    Rocket Lab’s Rockets: Faster, Larger, and Now Reusable

  • By Published On: December 19, 2022

    7investing’s 2022 Year in Review: An Updated Look at All of Our Stock Picks

  • By Published On: November 22, 2022

    7investing Company Update Roundup: November 2022

  • By Published On: November 3, 2022

    A Fresh Look at Meta: Expenses Only a Founder Could Love